NCT05211336 Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05109312 A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401. Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05076110 Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures Status COMPLETED Phase PHASE4
NCT05035407 T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers Status TERMINATED Phase PHASE1
NCT05013437 Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma Status WITHDRAWN Phase EARLY_PHASE1
NCT04939987 Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy Status WITHDRAWN Phase PHASE2/PHASE3
NCT04879823 Post-operative Course of Dexamethasone to Reduce Tonsillectomy Morbidity Status TERMINATED Phase PHASE3
NCT04840615 Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma Status TERMINATED Phase PHASE1
NCT04791761 Non-Opioid Pain Medications After Intracapsular Adenotonsillectomy Status TERMINATED Phase PHASE1/PHASE2
NCT04790812 Preemptive Analgesia With Celecoxib for Acute Dental Pain Management Status COMPLETED Phase PHASE4
NCT04779567 Usefulness of Acetaminophen Associated With Strong Opioids for Acute Pain in Cancer Patients Status COMPLETED Phase PHASE4
NCT04694300 OTC Naproxen and Acetaminophen Anti-Inflammatory Action in Dental Implant Patients Status COMPLETED Phase PHASE4
NCT04681105 Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies Status COMPLETED Phase PHASE1
NCT04662567 Oral Versus Intravenous Acetaminophen for Postoperative Pain Control Status TERMINATED Phase NA
NCT04646967 An Evaluation of Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision Status COMPLETED Phase PHASE2
NCT04629248 A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy Status ACTIVE_NOT_RECRUITING Phase PHASE3